Article Figures & Data
Figures
- Fig 1.
Predictive value of gadolinium-enhanced MR imaging for relapses in MS: a meta-analysis. Reprinted with permission from Lancet.24
- Fig 2.
Typical MS with brain lesions.
- Fig 3.
Comparison of rates of Gd3+ release for 1 mmol/L solutions of gadolinium-containing contrast agents in native human serum from healthy volunteers at 37°C. Reprinted with permission from Frenzel T, Lengsfeld P, Shirmer H, et al. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37°C. Invest Radiol 2008;43:817–28.
- Fig 4.
Case study shows brain lesion enhancement with gadobutrol. Images were obtained at 3, 6, 9, and 12 minutes postinjection.
In this issue
Jump to section
Related Articles
Cited By...
- Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 1--Mechanisms, Efficacy, and Safety
- Multiple Sclerosis: An Update
- MS Lesions Are Better Detected with 3D T1 Gradient-Echo Than with 2D T1 Spin-Echo Gadolinium-Enhanced Imaging at 3T
- Accuracy of Postcontrast 3D Turbo Spin-Echo MR Sequence for the Detection of Enhanced Inflammatory Lesions in Patients with Multiple Sclerosis
- Practice patterns of US neurologists in patients with SPMS and PPMS: A consensus study